Data / Form D filings / HYPERION THERAPEUTICS INC
HYPERION THERAPEUTICS INC: Form D filings
HYPERION THERAPEUTICS INC, a pharmaceuticals company in Brisbane, CA, filed 5 Form D notices with the SEC between 2009 and 2014. The latest, on June 18, 2014, reports $8 million sold of a $8 million offering.
Find out what HYPERION THERAPEUTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2000 Sierra Point Parkway, Suite 400, Brisbane, CA, 94005
- Phone
- (650) 745-7802
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $25,000,001 - $100,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1386858
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 18, 2014 | New notice | $7,990,674 | $7,990,674 | $0 | 0 | Jun 12, 2014 | sec.gov |
| Nov 4, 2011 | New notice | $15,030,000 | $7,500,749 | $7,529,251 | 10 | Oct 26, 2011 | sec.gov |
| Apr 18, 2011 | New notice | $35,000,000 | $17,471,998 | $17,528,002 | 10 | Apr 1, 2011 | sec.gov |
| Jul 16, 2009 | New notice | $45,461,554 | $21,981,863 | $23,479,691 | 9 | Jun 29, 2009 | sec.gov |
| May 14, 2009 | New notice | $15,000,000 | $12,988,762 | $2,011,238 | 12 | Aug 5, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bo Jesper I. Hansen | Director | |
| Christine A. Nash | Executive Officer | |
| Natalie A. Holles | Executive Officer | |
| Jake R. Nunn | Director | |
| Bijan R. Salehizadeh | Director | |
| Daniel G. Welch | Director | |
| Ashley A. Gould | Executive Officer | |
| Lota S. Zoth | Director | |
| Donald J. Santel | Executive Officer | |
| Klara A. Dickinson | Executive Officer | |
| Bruce F. Scharschmidt | Executive Officer | |
| Jeffrey S. Farrow | Executive Officer | |
| James I. Healy | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jun 16, 2014 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what HYPERION THERAPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.